UMSOM receives $29 million research award to improve health outcomes in people who inject opioid drugs

University of Maryland School of Medicine Dean Mark T. Gladwin, MD, announced today that the school will receive a $29 million research award over four years from the National Institutes of Health to lead a multicenter trial that aims to improve health outcomes in people who inject opioid drugs and are hospitalized with infectious complications of their drug use.

Related Keywords

United States ,Maryland ,Baltimore ,Washington ,National Institutes Of Health ,University Of Maryland Medical Center ,Virginia ,University Of Maryland ,University Of Maryland School Medicine ,Americans ,America ,Marylanders ,Edward Traver ,Elana Rosenthal ,Akikok Bowers ,Sarah Kattakuzhy ,Shyamasundaran Kottilil ,Chris Van Hollen ,Henry Masur ,Markt Gladwin ,Institute Of Human Virology ,George Washington University ,Critical Care Medicine Department ,Division Of Clinical Care ,Research Initiative On Infectious Disease ,Kahlert Institute ,End Addiction Initiative ,Clinical Care Center ,Emory University ,Kahlert Institute For Addiction Medicine ,Virginia University ,Maryland School ,Dean Mark ,National Institutes ,Human Virology ,Addiction Medicine ,End Addiction Long Term Initiative ,Hospitalized Patients ,Opioid Use Disorder ,Infectious Complications ,Drug Use ,Associate Professor ,Assistant Professor Medicine ,Co Principal Investigator ,Associate Director ,Ben Cardin ,Distinguished Professor ,Vice President ,Medical Affairs ,Infectious Disease ,Substance Use ,Maryland Medical Center ,West Virginia ,Care Center ,Clinical Care ,Drs Kattakuzhy ,National Institute ,Health Helping ,Medicine ,Addiction ,Flood ,Drugs ,Endocarditis ,Health Care ,Heart ,Shiv ,Hospital ,Opioids ,Overdose ,Research ,Substance Use Disorder ,Virology ,